Research on the Relationship Between Serum Levels of Inflammatory Cytokines and Non-small Cell Lung Cancer
Authors:
- Shi-Jie ZhouSZShi-Jie Zhou
- Ning XiaoNXNing Xiao
- Yun-Song LiYLYun-Song Li
- De-Zhi ZhenDZDe-Zhi Zhen
- Chong-Yu SuCSChong-Yu Su
- Zhi-Dong LiuZLZhi-Dong Liu
Open Access
- 30 August 2013
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 14 (8) , 4765-4768
Abstract
Research on the Relationship Between Serum Levels of Inflammatory Cytokines and Non-small Cell Lung Cancer TNF-${\alpha}$;IL-6;IL-8;VEGF;serum values;non-small cell lung cancer; Aims: This study was conducted to evaluate the levels of TNF-${\alpha}$, IL-6, IL-8 and VEGF in serum of patients with non- small cell lung cancer, for assessing their possible diagnostic and prognostic roles. Methods: We enrolled 48 patients newly diagnosed with non-small cell lung cancer and 40 healthy controls. TNF- ${\alpha}$, IL-6 and IL-8 levels were measured in the serum of all the subjects with specific radioimmunoassay kits, while EGF was analyzed by sandwich enzyme immunoassay techniques. Results: A statistically significant difference was observed between lung cancer patients and the control group regarding the values of TNF-${\alpha}$, IL-6, IL-8 and VEGF in serum. Moreover, TNF-${\alpha}$, IL-8 and VEGF levels were higher in patients with advanced stages compared to early stages. In addition, higher serum levels of TNF-${\alpha}$, IL-6, IL-8 and VEGF were found in smokers than in non-smokers, both in patients and controls. Conclusion: Serum levels of TNF-${\alpha}$, IL-6, IL-8 and VEGF were all elevated in lung cancer patients, suggesting that inflammatory cytokines could be jointly used as a screening tool. Though TNF-${\alpha}$, IL-8 and VEGF levels were related to advanced disease, long-term survival studies of NSCLC patients should be performed to confirm whether they can act as biomarkers of advanced disease. In addition, smoking would be an important contributor to the processes of inflammation and lung cancer.
Keywords
This publication has 20 references indexed in Scilit:
- An Integrated Expression Profiling Reveals Target Genes of TGF-β and TNF-α Possibly Mediated by MicroRNAs in Lung Cancer CellsPLOS ONE, 2013
- Inflammatory Biomarkers and Risk of Lung CancerJNCI: Journal of the National Cancer Institute, 2011
- Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung CancerJNCI: Journal of the National Cancer Institute, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Circulating Human Interleukin-8 as an Indicator of Cancer Progression in a Nude Rat Orthotopic Human Non–Small Cell Lung Carcinoma ModelCancer Epidemiology, Biomarkers & Prevention, 2008
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- C-Reactive Protein Levels, Variation in the C-Reactive Protein Gene, and Cancer Risk: The Rotterdam StudyJournal of Clinical Oncology, 2006
- Serum Vascular Endothelial Growth Factor (VEGF) and Bcl-2 Levels in Advanced Stage Non-Small Cell Lung CancerCancer Investigation, 2006
- Circulating Levels of Inflammatory Markers and Cancer Risk in the Health Aging and Body Composition CohortCancer Epidemiology, Biomarkers & Prevention, 2005
- Inflammation and cancerNature, 2002